Furthermore, dimensionality reduction followed by FlowSOM clustering identified multiple clusters based on their expression of CD4, CD45RA, CCR6, CCR4 and CXCR3, which were expanded or reduced in MS patients compared to controls (Fig. 1C and E and Supplementary Fig. 1A–C). The gene discussed is CXCR3; the disease is myeloid sarcoma.